PSX Company Profiles

What listed companies do, how they make money, key financials and Shariah status, researched by the PSX Investors Zone team.

Clear

5 companies

ABOT

Pharmaceuticals

Abbott Laboratories (Pakistan) Limited

Abbott Laboratories (Pakistan) Limited (PSX: ABOT) is a Pakistani pharmaceutical and healthcare company incorporated in 1948. Its business includes branded generic medicines, nutritional products, diagnostics, diabetes care, hospital products and consumer healthcare products. Explore its financial performance, dividend history, Shariah-screening status and key business risks before conducting further investment research.

AGP

Pharmaceuticals

AGP Limited

AGP Limited (AGP) is a Pakistan Stock Exchange-listed pharmaceutical company involved in importing, marketing, exporting, distributing, wholesaling and manufacturing pharmaceutical products. In 2025, it reported standalone sales of approximately Rs. 20.55 billion, profit after tax of Rs. 2.36 billion and EPS of Rs. 8.43. Its portfolio and subsidiaries support its presence across Pakistan’s healthcare market. Investors should examine earnings growth, product demand, regulatory requirements, distribution costs, debt and the latest Shariah screening before making investment decisions.

FEROZ

Pharmaceuticals

Ferozsons Laboratories Limited

Ferozsons Laboratories Limited (PSX: FEROZ) is a Pakistani pharmaceutical company incorporated in 1954 that commenced commercial operations in 1956. Its core business includes importing, manufacturing and selling pharmaceutical products and medical devices. The company also has interests in BF Biosciences Limited, a pharmaceutical business, and Farmacia, a medicine retail and distribution venture. For FY2026, Ferozsons reported standalone revenue of approximately Rs. 15.76 billion, profit after tax of Rs. 650.90 million and EPS of Rs. 14.97. On a consolidated basis, revenue reached Rs. 23.96 billion and profit after tax was approximately Rs. 1.23 billion, with consolidated EPS of Rs. 22.51. The board recommended a final cash dividend of Rs. 5.50 per share for FY2026, subject to shareholder approval at the AGM scheduled for October 28, 2026. Ferozsons appeared as Shariah-compliant in the PSX-KMI All Share Islamic Index screening information effective June 5, 2026, based on December 2025 data. Investors should verify the latest screening status. **Important PSX Risk Warning:** The official PSX company page displays an alert concerning continuous violation of specified listing-regulation clauses and potential trading suspension or delisting. Investors should review the latest official notice and company disclosures before making investment decisions.

HCAR

Automobile Assembler

Honda Atlas Cars (Pakistan) Limited

Honda Atlas Cars (Pakistan) Limited (PSX: HCAR) assembles and sells Honda vehicles and spare parts in Pakistan. For FY2026, PSX standardized financial data reports sales of Rs.122.28 billion, profit after tax of Rs.3.23 billion and EPS of Rs.22.64. The company declared a final cash dividend of Rs.9 per share for the year ended March 31, 2026. HCAR’s performance depends on vehicle demand, consumer purchasing power, exchange rates, import policies, production costs and competition. Its PSX profile also displays a Risk Warning Alert relating to potential suspension or delisting, which investors should review alongside the latest official disclosures.

SEARL

Pharmaceuticals

The Searle Company Limited

The Searle Company Limited (PSX: SEARL) is a Pakistani pharmaceutical company engaged in manufacturing pharmaceutical and consumer products. Incorporated in 1965, it operates in Pakistan's healthcare and medicines market. In FY2026, the company reported sales of approximately Rs. 31.64 billion, profit after tax of Rs. 4.00 billion and earnings per share of Rs. 6.81. Investors researching SEARL should assess its earnings recovery, product portfolio, margins, regulatory environment, cash flow, Shariah screening status and the Risk Warning Alert displayed on its PSX profile. Past financial performance does not guarantee future results. Sources: https://dps.psx.com.pk/company/SEARL | https://searlecompany.com/investor-information/